Navigation Links
Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
Date:10/10/2008

ent a Featured Lecture on "Revascularization in Patients with Unprotected Left Main Coronary Artery Disease," while Dr. Mohr will present on "Revascularization in Patients with Triple Vessel Coronary Artery Disease." SYNTAX is the first randomized, controlled clinical trial comparing PCI using drug-eluting stents to CABG in patients with left main and/or three-vessel disease. The Company plans to issue a press release at this time. Dr. Serruys will present additional details on the SYNTAX Score during his Featured Lecture as well as during Tuesday's Focus on SYNTAX Sessions in a presentation titled "SYNTAX Score: Methodology and Importance."

-- Focus on SYNTAX. From 2:00 -- 6:00 p.m., a series of focus sessions titled "Revascularization for Left Main and Triple-Vessel Disease: Focus on SYNTAX" will take place in Room 147AB. Details on the topics and presenters can be found in the official TCT program.

-- Symposium on SYNTAX Trial Data. From 8:00 -- 10:00 p.m., the Company will sponsor a symposium entitled "The SYNTAX Trial: Understanding the Data in Complex Anatomies and Advanced Disease," chaired by Dr. Serruys in the Grand Ballroom of the Renaissance Hotel. The symposium will offer an overview of the latest SYNTAX trial data and feature a panel discussion on subset case presentations for patients with multi-vessel disease and left main disease. The symposium will include panel members Ted E. Feldman, M.D., Michael J. Mack, M.D., Martin B. Leon, M.D., and Friedrich W. Mohr, M.D. A reception will be held prior to the symposium at 7:00 p.m.

Wednesday, October 15

-- OLYMPIA High-Risk Subgroups. One-year results from Intercontinental and European Launch Phases of the global OLYMPIA registry will be presented in an oral abstract session by Waqar H. Ahmed, M.D., M.S., FACC, at 8:41 a.m., in Room 145AB. OLYMPIA is the world's largest prospective, multi-center, multi-phased registry for a single drug-eluting stent. The registry is designed to an
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- IBM Watson Health (NYSE: IBM ) today announced ... leading cancer institutes to accelerate the ability of clinicians ... The institutes will apply Watson,s ... the ability to translate DNA insights, understand a person,s ... to personalize treatment options. The project is part of ...
(Date:5/5/2015)... 5, 2015 (Family Features) Which health screenings ... like most adults, monitoring your weight, cholesterol, and blood ... But what about vision care? Photo ... reach their 40s, they often start to notice small ... lives and job performance. Whether having difficulty reading a ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... CEO Yaacov Shoham today issued the following statement, ... and asked them to upgrade IDenta,s current tier. They are ... 1. Annual financial report (audited) for year 2011 ( ... Statement The files can be found at the ...
... Mass., April 26, 2012  Sensitech Inc., the global ... the International Air Transport Association (IATA) has deemed ... devices to be in compliance with the 53rd ... Provision (SP) 188 published by the United Nations.   ...
Cached Medicine Technology:International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets. 2Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Health IVF Clinic in Greece, an experienced team ... and treatment of infertility for patients around the globe. ... partnered with VisitandCare.com. Greece unquestionably remains a global leader ... most talented and hard-working fertility specialists in the world ...
(Date:5/5/2015)... York (PRWEB) May 05, 2015 ... http://www.testosteronelawsuithub.com/ ) filed on behalf of men ... to their use of prescription testosterone replacement ... federal multidistrict litigation underway in U.S. District ... court documents dated May 1st, defendants AbbVie, ...
(Date:5/5/2015)... Baptist Medical Center Jacksonville’s cancer program ... of the American College of Surgeons. , To earn ... than 30 Commission on Cancer quality care standards, be ... maintain levels of excellence in the delivery of comprehensive ... seek care locally at a CoC-accredited cancer center, they ...
(Date:5/5/2015)... Skedans Systems a division of ... Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems ... developers, provides tooling to deliver real time information for ... Skedans Sensor Collaboration Platform is a single unified cloud ... Things, Web Real Time Communications (WebRTC), and commercial Unmanned ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... SHANGHAI, China, Oct. 5 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: ... Chinese firm,specializing in the manufacture, research, development, marketing ... of its,previously announced underwritten public offering. The Company ... per share in its public offering,resulting in approximately ...
... is estimated that more than 7,000 people are diagnosed with ... approximately 3,500 cases result in death. These cancers include ... some have been linked to the sexually transmitted infection, HPV-16. ... 90 cancerous tissue samples to look for genes that indicated ...
... the University of Santiago de Compostela (USC) has established that ... soft drinks are far higher than those indicated on their ... to a new technique developed by the researchers to determine ... Ascorbic acid or vitamin C is a ...
... Trapeze Networks, a Belden Brand (NYSE: BDC ... the goal of extending the company,s leadership in the ... focused on three strategies: It will increase the ... clinics and residential care facilities, help Trapeze Networks, cadre ...
... (ARI) states that many diagnosed with autism have underlying ... parents, researchers, and clinicians from around the world will ... ARI/Defeat Autism Now! Conference in Dallas, TX. , ... published results from a 2007 telephone survey in ...
... ... "Boost Your Juice Contest" in October, in which healthcare and wellness businesses can participate ... campaign worth up to $5,000. , ... Phoenix, AZ (PRWEB) October 5, 2009 -- As confusion reigns in ...
Cached Medicine News:Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 3Health News:DNA test could be key to targeting treatments for head and neck cancer 2Health News:Fruit juices contain more vitamin C than their labels indicate 2Health News:Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market 2Health News:New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered 2Health News:Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 2Health News:Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: